Published in Postgrad Med J on October 01, 2000
Hughes-Stovin syndrome. Orphanet J Rare Dis (2011) 1.30
Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol (2008) 1.05
Massive hemoptysis and deep venous thrombosis presenting in a woman with Hughes-Stovin syndrome: a case report. J Med Case Rep (2010) 0.99
Behçet's Disease as a Model of Venous Thrombosis. Open Cardiovasc Med J (2010) 0.95
Gender and ocular manifestations of connective tissue diseases and systemic vasculitides. J Ophthalmol (2014) 0.83
Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Rheumatol Int (2004) 0.80
The seroprevalence of varicella zoster antibodies in Behçet's and other skin diseases. Eur J Epidemiol (2003) 0.77
Genital aphthosis in Behçet's disease: is it associated with less eye involvement? Rheumatol Int (2014) 0.76
Otolaryngologic Manifestations of Various Rheumatic Diseases: Awareness and Practice Among Otolaryngologists. Indian J Otolaryngol Head Neck Surg (2015) 0.76
Urgent Surgical Management of Deep Femoral Artery Aneurysm in a Patient with Pre-Vasculo-Behcet Status. Ann Vasc Dis (2015) 0.75
Demographical and Clinical Characteristics of Behcet's Disease in Southeastern Turkey. J Clin Med Res (2014) 0.75
Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center. Hippokratia (2007) 0.75
Behcet's disease presenting as new onset of confusion in a male patient of North African origin in the UK. BMJ Case Rep (2010) 0.75
The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Magnetization transfer ratio in neuro-Behçet disease. Neuroradiology (2005) 0.75
Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Vascular involvement in Behçet's disease. J Rheumatol (1992) 4.86
Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis (1977) 3.08
Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol (1995) 2.95
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.78
Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr (1998) 2.51
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Behçet's Disease. Semin Arthritis Rheum (1998) 2.23
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease and the nervous system. J Neurol (1998) 1.92
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet (1989) 1.92
Description of Behçet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol (1956) 1.90
The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis (1983) 1.86
Periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J (1989) 1.77
Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet (1982) 1.73
The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial. Arthritis Rheum (1996) 1.72
Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis (1984) 1.56
Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J (1994) 1.53
A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis (1984) 1.53
Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol (1994) 1.52
Behçet's disease and pregnancy relationship study. Br J Rheumatol (1997) 1.52
Plasma endothelin-1 levels in Behçet's disease. Clin Rheumatol (1997) 1.48
Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
Cardiac involvement in Behçet's disease. Cardiology (1998) 1.42
Coronary anomaly in Behçet's syndrome. Rheumatol Int (1997) 1.40
Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease. Am J Med (1984) 1.37
T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol (1993) 1.37
Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol (1997) 1.29
Budd-Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol (1997) 1.28
Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol (1997) 1.26
Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome. Clin Exp Immunol (1978) 1.26
Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis (1997) 1.23
The pathergy test and Behçet's syndrome in Britain. Ann Rheum Dis (1984) 1.22
Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum (1995) 1.21
The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc (1979) 1.21
Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum (1997) 1.21
Behçet's disease as seen in Turkey. Haematologica (1980) 1.21
Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol (1995) 1.19
Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis (1991) 1.16
Post-surgical pyoderma gangrenosum of the vaginal vault associated with ulcerative colitis and Behçet's disease; a case report. Eur J Obstet Gynecol Reprod Biol (1989) 1.12
Behçet's syndrome. Curr Opin Rheumatol (1999) 1.11
Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol (1992) 1.09
A double blind study of colchicine in Behçet's disease. Haematologica (1980) 1.07
Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol (1998) 1.07
A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens (1997) 1.06
Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis (1993) 1.06
Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology (1999) 1.06
Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol (1988) 1.06
Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J (1997) 1.04
Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease. Dermatology (1996) 1.04
Natural killer cells in Behçet's disease. Clin Exp Immunol (1988) 1.04
The ten-year mortality in Behçet's syndrome. Br J Rheumatol (1996) 1.01
Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis (1986) 1.01
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol (1989) 1.00
Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg (1997) 0.99
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease. Am J Ophthalmol (1994) 0.98
Arthropathy in Behçet's disease. Scand J Rheumatol (1997) 0.97
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol (1993) 0.97
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Behçet's syndrome in Scotland. Postgrad Med J (1992) 0.96
Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms. Ann Rheum Dis (1989) 0.96
TNF, soluble IL-2R and soluble CD-8 in Behçet's disease. J Rheumatol (1990) 0.96
Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome): a case report and literature review. Am J Med Sci (1997) 0.96
Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci (1998) 0.95
Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease. Cell Immunol (1992) 0.95
Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J Am Acad Dermatol (1990) 0.95
Childhood Behçet's disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford) (1999) 0.95
Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol (1998) 0.91
Familial occurrence of Behçet's disease. Jpn J Ophthalmol (1996) 0.90
Role of mucosal injury in initiating recurrent aphthous stomatitis. Br Med J (Clin Res Ed) (1981) 0.90
HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol (1988) 0.89
Molecular genetics (HLA) of Behçet's disease. Yonsei Med J (1997) 0.89
Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol (1992) 0.89
Behçet's disease and amyloidosis. Review of the literature. Scand J Rheumatol (1997) 0.87
Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol (1991) 0.85
Rheumatic disorders of the eye and the various structures involved. Br J Rheumatol (1996) 0.84
A case of Adamantiadis-Behçet's syndrome presenting as myocardial infarction. Clin Exp Rheumatol (1993) 0.83
A descriptive study on Behçet's disease. Acta Ophthalmol Scand (1996) 0.82
Aortic regurgitation secondary to Behçet's disease. A case report and review of the literature. Eur Heart J (1990) 0.82
IgA nephritis in Behçet's disease: case report and review of the literature. Clin Nephrol (1990) 0.82
HLA B51 antigen associated with neutrophil hyper-reactivity. Dis Markers (1992) 0.81
Acute febrile neutrophilic dermatosis (Sweet's syndrome) in neuro-Behçet's disease. Clin Neurol Neurosurg (1993) 0.81
Dermatologic manifestation of Behçet's disease. Yonsei Med J (1997) 0.80
Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol (1991) 0.80
Effect of cyclosporine A on the hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol (1991) 0.80
IgA nephropathy in a patient with Behçet's syndrome--case report and review of literature. Br J Rheumatol (1997) 0.80
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]. Ryumachi (1995) 0.78
Sweet's syndrome associated with Behçet's disease. Australas J Dermatol (1996) 0.78
Fibromyalgia in Behçet's syndrome. J Rheumatol (1998) 0.78
[Behçet's disease and streptococcal antigens]. Nippon Ganka Gakkai Zasshi (1996) 0.76
Impaired prostacyclin synthesis by vessel walls in Behçet's disease. Lancet (1986) 0.76
Immunopathology of Behçet's disease. Postgrad Med J (1991) 0.76
[PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis]. Schweiz Med Wochenschr (1997) 0.76
[Value of "bolus" cyclophosphamide injections in Behçet's disease. Experience of 17 cases]. Presse Med (1990) 0.75
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis (1994) 1.67
Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology (2001) 1.64
Road traffic accidents and diabetes: insulin use does not determine risk. Diabet Med (2008) 1.63
Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc (1997) 1.49
Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford) (1999) 1.48
Early results of infragenicular revascularization based solely on duplex arteriography. J Vasc Surg (2001) 1.39
Autoantibodies in pet dogs owned by patients with systemic lupus erythematosus. Lancet (1992) 1.38
Comparison of the ETDRS logMAR, 'compact reduced logMar' and Snellen charts in routine clinical practice. Eye (Lond) (2009) 1.34
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30
Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) (2005) 1.26
Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med (2000) 1.25
Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol (2004) 1.25
The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol (1993) 1.22
The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure. Arch Surg (1989) 1.20
The interarm blood pressure difference as predictor of cardiovascular events in patients with hypertension in primary care: cohort study. J Hum Hypertens (2007) 1.16
The efficacy of sirolimus in the treatment of patients with refractory uveitis. Br J Ophthalmol (2005) 1.15
Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J Biol Chem (1991) 1.14
Linkage of familial Hibernian fever to chromosome 12p13. Am J Hum Genet (1998) 1.14
Epoprostenol in systemic capillary leak syndrome. Lancet (1988) 1.11
Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guérin: review of primary aortoduodenal fistula without abdominal aortic aneurysm. J Vasc Surg (2001) 1.11
Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res (1997) 1.10
Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study. Ann Rheum Dis (1998) 1.08
Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology (1999) 1.06
Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol (2003) 1.04
Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells. Lupus (2003) 1.03
Effect of thalidomide on orogenital ulceration. Br Med J (Clin Res Ed) (1983) 1.02
C reactive protein concentrations in neonates: determination by a latex enhanced immunoassay. J Clin Pathol (1984) 1.02
Wegener's granulomatosis--a review of diagnosis and treatment in 53 subjects. Rhinology (1998) 1.01
Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline. Ann Rheum Dis (1993) 0.99
Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms. Br J Rheumatol (1988) 0.98
Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity. J Rheumatol (1985) 0.98
Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis (1996) 0.97
An improved assay for IgG rheumatoid factor: its value in the diagnosis of rheumatoid arthritis. J Rheumatol (1985) 0.97
Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms. Ann Rheum Dis (1989) 0.96
A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice. J Vasc Surg (1999) 0.94
A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc Endovasc Surg (1997) 0.94
Mammalian polypeptide chain release factor and tryptophanyl-tRNA synthetase are distinct proteins. EMBO J (1993) 0.94
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford) (2007) 0.93
Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis. Ann Rheum Dis (1986) 0.93
Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis (1994) 0.92
Poststreptococcal reactive arthritis. Ann Rheum Dis (1990) 0.91
Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis (1994) 0.90
Autoantibodies, immunoglobulins and Gm allotypes in nodal generalized osteoarthritis. Br J Rheumatol (1992) 0.90
C3 nephritic factor and SLE: report of four cases and review of the literature. QJM (1994) 0.90
Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Clin Invest (1995) 0.89
An investigation into variability in microvascular skin blood flow and the responses to transdermal delivery of acetylcholine at different sites in the forearm and hand. Br J Clin Pharmacol (1997) 0.89
Superficial femoral artery stenoses: characteristics of progressing lesions. J Vasc Surg (1997) 0.89
Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol (1999) 0.89
Toxoplasmosis and systemic lupus erythematosus. Ann Rheum Dis (1990) 0.88
Inclusion body myositis: an underdiagnosed condition? Ann Rheum Dis (1993) 0.88
Tacrolimus immunosuppression in high-risk corneal grafts. Br J Ophthalmol (2006) 0.87
Restrictions of T cell receptor beta chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Ann Rheum Dis (1996) 0.86
Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. J Biotechnol (1996) 0.86
Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens. Thorax (1992) 0.85
IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Ann Rheum Dis (1998) 0.85
The pathobiology of diabetes mellitus: implications for surgeons. J Am Coll Surg (1996) 0.85
Determinants of insulin concentrations in healthy 1-week-old babies in the community: applications of a bloodspot assay. Early Hum Dev (2005) 0.84
Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon. Br J Clin Pharmacol (2001) 0.84
Classical complement activation induced by pregnancy: implications for management of connective tissue diseases. J Clin Pathol (1992) 0.84
Ambient pulsatile pressure modulates endothelial cell proliferation. J Mol Cell Cardiol (1998) 0.84
Human anti-fibronectin antibodies in systemic lupus erythematosus: occurrence and antigenic specificity. Clin Exp Immunol (1994) 0.84
Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis (1994) 0.84
Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products. Ann Rheum Dis (1993) 0.84
Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. J Autoimmun (2001) 0.83
Screening of acute psychiatric admissions for previously undiagnosed systemic lupus erythematosus. Br J Psychiatry (1992) 0.83
Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis (2000) 0.83
C3 degradation products (C3d) in normal pregnancy. J Clin Pathol (1987) 0.82
Surgical smoke - a health hazard in the operating theatre: a study to quantify exposure and a survey of the use of smoke extractor systems in UK plastic surgery units. J Plast Reconstr Aesthet Surg (2012) 0.82
Distribution of cases of systemic lupus erythematosus at time of first symptom in an urban area. Ann Rheum Dis (1995) 0.82
Vascular smooth muscle cell effect on endothelial cell endothelin-1 production. J Vasc Surg (2000) 0.82
Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis (1993) 0.82
Clinically useful monoclonal antibodies in treatment. J Clin Pathol (2002) 0.82
Thalidomide in severe orogenital ulceration. Lancet (1984) 0.81
New roles for thalidomide. BMJ (1996) 0.81
Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis (1997) 0.81
Paternal insulin resistance and its association with umbilical cord insulin concentrations. Diabetologia (2006) 0.81
The influence of anti-fibronectin antibodies on interactions involving extracellular matrix components and cells: a possible pathogenic mechanism. Clin Exp Immunol (1994) 0.81
Focal myositis: an unusual cause of bilateral upper eyelid swellings. Postgrad Med J (1993) 0.80
Familial Mediterranean fever. Lancet (1996) 0.80
Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) (2004) 0.80
Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons. Clin Exp Immunol (1995) 0.80
Management of systemic lupus erythematosus (SLE). Clin Exp Allergy (2001) 0.79
Systemic lupus erythematosus with widespread subcutaneous fat calcification. Proc R Soc Med (1974) 0.79
Use of thalidomide in dermatological indications. BioDrugs (2000) 0.79
A randomized controlled trial of postoperative analgesia following total knee replacement: transdermal Fentanyl patches versus patient controlled analgesia (PCA). Eur J Orthop Surg Traumatol (2015) 0.78
Effect of alpha-tocopherol on red cell deformability and survival in sepsis. Curr Surg (1989) 0.78
Basaloid follicular hamartoma, total body hair loss and SLE. Lupus (1998) 0.78
Estimating the incidence of SLE. Br J Rheumatol (1990) 0.78
Effect of aprotinin on smooth muscle cell proliferation, migration, and extracellular matrix synthesis. J Surg Res (1996) 0.78
Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide. Br J Dermatol (1985) 0.78
Tuberculosis and treatment with infliximab. N Engl J Med (2002) 0.78
Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus. Ann Rheum Dis (1995) 0.78
Cladribine in the treatment of systemic lupus erythematosus nephritis. Ann Rheum Dis (1999) 0.77
Arthropathy, leucopenia and recurrent infection associated with a TcR gamma delta population. Br J Rheumatol (1995) 0.77
Peripheral blood lymphocyte binding to a soluble FITC-fibronectin conjugate. Cytometry (1997) 0.77
Dermatomyositis following chronic staphylococcal joint sepsis. Ann Rheum Dis (1990) 0.77
Selective activation of circulating CD4+ lymphocytes in severe adult atopic dermatitis. Br J Dermatol (1992) 0.77